News | Breast Density | February 14, 2019

Densitas Enters Partnership Agreement With TeleMammography Specialists

Teleradiology provider will be first U.S. beta user for new densitasquality solution to enhance communication and compliance with FDA EQUIP mammography inspection program

Densitas Enters Partnership Agreement With TeleMammography Specialists

February 14, 2019 — Breast imaging analytics company Densitas Inc. announced a new collaboration partnership with TeleMammography Specialists of Decatur, Ga. TeleMammography Specialists will be the first U.S. beta user for the new densitasquality solution from Densitas, which will be used to improve the communications and information sharing needed to meet EQUIP (Enhancing Quality Using the Inspection Program) guidelines. TeleMammography Specialists will also implement the recently released densitasdensity automated breast density assessment software.

Densitas will highlight the benefits and capabilities of both products at the 2019 Healthcare Information and Management Systems Society (HIMSS) annual meeting, Feb. 11-15 in Orlando, Fla.

TeleMammography Specialists LLC. is an international teleradiology services provider that is specialized in breast imaging. Densitas Quality will help:

  • Streamline efforts to meet the U.S. Food and Drug Administration’s (FDA) EQUIP guidelines and prepare for mammography inspections;
  • Enable real-time feedback from the interpreting physicians to the technologists;
  • Automate EQUIP audit documentation requirements of the lead interpreting physician/auditing physician;
  • Simplify the ability to meet the proactive quality control requirements of EQUIP; and
  • Identify technologist performance issues quickly and accurately to facilitate ongoing training and communication that improves image and service quality.

By making densitasquality and densitasdensity available to all of TeleMammography Specialists clients, over 60,000 women will benefit annually. "Densitas will help us provide consistent quality and standardize density assessment among our radiologists", said Martha H. Garrison, M.D., president and CEO of TeleMammography Specialists, LLC. "We will be able to more proactively manage the needs of our clients and provide consistently high quality of care."

The artificial intelligence (AI)-powered densitasdensity software delivers fully automated, standardized and reliably reproducible breast density assessment. Additionally, densitasdensity results can be incorporated in risk models to generate standardized and reliably reproducible breast cancer risk assessment.

For more information: www.densitas.health

Related Content

Brain images that have been pre-reviewed by the Viz.AI artificial intelligence software to identify a stroke. The software automatically sends and alert to the attending physician's smartphone with links to the imaging for a final human assessment to help speed the time to diagnosis and treatment. Depending on the type of stroke, quick action is needed to either activate the neuro-interventional lab or to administer tPA. Photo by Dave Fornell.

Brain images that have been pre-reviewed by the Viz.AI artificial intelligence software to identify a stroke. The software automatically sends and alert to the attending physician's smartphone with links to the imaging for a final human assessment to help speed the time to diagnosis and treatment. Depending on the type of stroke, quick action is needed to either activate the neuro-interventional lab or to administer tPA. Photo by Dave Fornell.

Feature | Artificial Intelligence | May 17, 2019 | Inga Shugalo
With its increasing role in medical imaging,...
Managing Architectural Distortion on Mammography Based on MR Enhancement
News | Mammography | May 15, 2019
High negative predictive values (NPV) in mammography architectural distortion (AD) without ultrasonographic (US)...
Clarius Releases Clarius Live Ultrasound Telemedicine Solution
Technology | Ultrasound Imaging | May 15, 2019
Clarius Mobile Health released a telemedicine solution called Clarius Live. The simple-to-use feature allows any...
FDA Clears Aidoc's AI Solution for Flagging Pulmonary Embolism
Technology | Artificial Intelligence | May 15, 2019
Artificial intelligence (AI) solutions provider Aidoc has been granted U.S. Food and Drug Administration (FDA)...
King's College London and NVIDIA Build U.K.'s First AI Platform for NHS Hospitals

King's College London will implement NVIDIA DGX-2 systems for AI research in the first phase of the project.

News | Artificial Intelligence | May 13, 2019
NVIDIA and King’s College London announced they are partnering to build an artificial intelligence (AI) platform that...
FDA Approves Zebra Medical Vision's HealthPNX AI Chest X-ray Triage Product
Technology | Artificial Intelligence | May 13, 2019
Zebra Medical Vision has received U.S. Food and Drug Administration (FDA) 510(k) clearance for HealthPNX, an artificial...
IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium
News | Proton Therapy | May 10, 2019
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain...
Screening MRI Detects BI-RADS 3 Breast Cancer in High-risk Patients
News | MRI Breast | May 09, 2019
When appropriate, short-interval follow-up magnetic resonance imaging (MRI) can be used to identify early-stage breast...
Novel Artificial Intelligence Method Predicts Future Risk of Breast Cancer
News | Artificial Intelligence | May 08, 2019
Researchers from two major institutions have developed a new tool with advanced artificial intelligence (AI) methods to...